Enthesitis can also occur with another common symptom of PsA, dactylitis. This is a painful inflammation of a finger or a toe. Enthesitis can cause long-lasting (chronic) inflammation, which can ...

Meanwhile, physicians additionally gave priority to several clinical manifestations — including enthesitis, dactylitis and skin disease — while patients more often prioritized impact on daily ...

Clinicians placed a higher emphasis on specific disease manifestations, including dactylitis, enthesitis, psoriasis, comorbidities, and structural damage. They also prioritized disease management ...

Inclusion of dactylitis and enthesitis as entry criteria. Inclusion of monoarthritis and polyarthritis in addition to oligoarthritis. While the new criteria represent a step forward in many ways ...

Results In dactylitis, collateral ligament enthesitis was seen in nine digits (75%), extensor tendon enthesitis in six digits (50%), functional enthesitis (5 digits, 42%), abnormal enhancement at the ...

Besides clinical signs of arthritis, nail abnormalities were noticed. Pathological examination showed the occurrence of dactylitis characterised by diffuse neutrophil infiltration in 6 of 50 paws ...

A similar proportion of patients in the normouricaemic and hyperuricaemic cohorts achieved American College of Rheumatology responses, resolution of enthesitis and dactylitis, inhibition of structural ...

None of the EMMs (uveitis, psoriasis, IBD) or peripheral manifestations (peripheral arthritis, enthesitis, dactylitis) were more prevalent in patients with normal SIJs than in those with atypical ...

Patients with ankylosing spondylitis and IBD exhibit distinct clinical and radiographic features, compared against those without comorbid IBD.

Many of the risk factors for heart disease are continuing to increase. (HealthDay News) — Heart disease continues to be a leading cause of death, according to a report from the American Heart ...

Daprodustat for treating anaemia in people with chronic kidney disease [ID3987] Technology appraisal guidance TBC Infigratinib for treating relapsed or refractory advanced cholangiocarcinoma with ...